Brief: Gossamer Bio Announces $212 Mln Private Placement Financing
20/07/2023 13:18
July 20 (Reuters) - Gossamer Bio Inc GOSS.O :
* GOSSAMER BIO ANNOUNCES $212 MILLION PRIVATE PLACEMENT
FINANCING
* GOSSAMER BIO INC - INTENDS TO USE NET PROCEEDS FROM
PRIVATE
PLACEMENT TO FUND ONGOING DEVELOPMENT AND COMMERCIALIZATION OF
SERALUTINIB
Source text for Eikon: ID:nBwlw0f2a
Further company coverage: GOSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gossamer Bio
See all newsBrief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing